Research & DevelopmentFocused on bio-identical hormone therapy, our pipeline includes novel drug product candidates
TherapeuticsMD is investigating novel drug product candidates for their potential to address women’s key healthcare needs. The pipeline is focused on novel hormone therapies utilizing our proprietary SYMBODA™ technology. We are working with well-known chemical entities that have established safety and efficacy profiles: 17B-estradiol and progesterone.
CURRENT DEVELOPMENT PROGRAM STATUS